Navigation Links
Sustained Growth Forecast for Medical Devices and Drug Delivery Markets According to New Market Research Available from Global Information Inc.
Date:4/9/2012

FARMINGTON, Conn., April 9, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce 3 significant new Pharmaceutical and Medical Device market forecasts and research reports from its partner publisher, The Freedonia Group.

(Photo:  http://photos.prnewswire.com/prnh/20120409/CG84188)

Implantable Medical Devices to 2015

US demand for implantable medical devices will reach $52 billion in 2015, according to a new market research forecast, Implantable Medical Devices to 2015, from The Freedonia Group. This 7.7 percent annual increase benefits from technological advances and the development of next generation devices that will increase patient and provider confidence in implant products. The lack of alternative treatments for many chronic disorders and injuries will also help drive demand, but over the long term sales for medical implants will be challenged as insurance providers tighten control over implantation costs. However, the ability of medical implants to reduce overall treatment cost for many conditions, including osteoarthritis and chronic heart failure, will work in favor of growth for these products in the long term. 

An Executive Summary of these trends and more and free sample of the full report are available at http://www.giiresearch.com/report/fd234022-implantable-medical-devices-2015.html

Disposable Medical Supplies to 2016

By 2016, US demand for Disposable Medical Supplies will have reached $47 billion. This is according to The Freedonia Group's forecast for the Disposable Medical Supplies market research report published this month. US demand for disposable medical supplies is forecast to increase 4.3 percent annually to $46.7 billion in 2016, driven by an expanding volume of patient care activity spurred by aging demographic patterns, a rising incidence of diseases and disorders, and the extension of health insurance coverage by the Affordable Care Act of 2010. Demand will continue to build upward momentum as hospitals, outpatient facilities, and other health care establishments adopt more strict infection prevention safeguards. Health care cost containment pressures will remain the key moderating influence on growth in the US disposable medical supplies market, while hospitals and other medical providers become increasingly price sensitive as public and private health insurance concerns tighten restrictions on fees paid for patient procedures.

An Executive Summary of these trends and more and free sample of the full report are available at http://www.giiresearch.com/report/fd235745-disposable-medical-supplies-2016.html

Drug Delivery Systems to 2015

This new market research forecasts US drug delivery product demand to rise 7.4 percent yearly to reach $134 billion in 2015. Parenteral products will grow the fastest, led by monoclonal antibodies and polymer-encapsulated medicines. Other types expected to do well include prefilled dry powder and metered dose brachytherapy implants, and implantable drug delivery products.

This brand new market research study analyzes the $93.8 billion US drug delivery system industry, and presents historical demand data for the years 2000, 2005 and 2010, alongside forecasts for 2015 and 2020 by excipient (e.g., polymers, cellulose, minerals), product type (e.g., oral, parenteral, inhalation, implantable, transdermal) and application (e.g., central nervous system, respiratory, hormones, gastrointestinal).

The study also considers market environment factors, details industry structure, evaluates company market share and profiles 27 industry players, including Roche, GlaxoSmithKline and Becton Dickinson.

An Executive Summary and free sample of this report are available at http://www.giiresearch.com/report/fd230864-drug-delivery-systems-2015.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years
2. Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types
3. New Data From REALISTIC Study Showed Cimzia® (certolizumab pegol) Provided Rapid and Sustained Efficacy, Over 28 Weeks, in a Broad Population of Patients With Moderate to Severe Rheumatoid Arthritis (RA) Including Those Who Discontinued Prior Anti-T
4. Treatment With Enbrel® (etanercept) Shows Significant and Sustained Clinical Benefits in Rheumatoid Arthritis (RA) Patients With Moderately Active Disease
5. Sustained Release Injectables: Evolving Formulations, Improving Dosing Regimens
6. New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients With Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes
7. Insmeds ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections
8. NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil®
9. NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting
10. Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Reduction in Clinical Events in Patients for 18 Months Compared with Placebo
11. Counting Calories Inadequate for Sustained Weight Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/27/2016)... ... 2016 , ... A revolution is underway. Brooklyn-based company, ... for the millions of people who require these medical transport services annually. ... the use of technology. Now, SmartEMS has put forth an industry-changing app that ...
Breaking Medicine News(10 mins):